Author

Danfan Lin

Observed names: D F Lin, Lin, Danfan

Institutions: Nanfang Hospital, Southern Medical University

Observed institutions: Nanfang Hospital, Southern Medical University

ORCID: 0000-0002-2446-6011

Observed ORCID: 0000-0002-2446-6011

OpenAlex ID: A5101190356

Effects of writers, erasers and readers within miRNA‐related m6A modification in cancers

2022 · Huiru Feng, Xiaofei Yuan, et al. · Cell Proliferation · 61

Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA

2022 · Xiaofei Yuan, Hua Yang, et al. · BMC Cancer · 25

Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma

2023 · Linchong Cui, Zilu Chen, et al. · BMC Cancer · 19

Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinoma

2023 · Xiaofei Yuan, Huiru Feng, et al. · Journal of Cancer Research and Clinical Oncology · 15

Combination of smoking and Epstein-Barr virus DNA is a predictor of poor prognosis for nasopharyngeal carcinoma: a long-term follow-up retrospective study

2022 · Wanxia Li, Chao Yang, et al. · BMC Cancer · 8

Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma

2023 · Shuting Wu, Xiaofei Yuan, et al. · BMC Cancer · 4

Comparative Analysis of Hearing Loss Induced by Cisplatin Versus Carboplatin in Locally Advanced Nasopharyngeal Carcinoma: Early to Mid‐Term Findings

2025 · Danfan Lin, Yanfei Li, et al. · Clinical Otolaryngology · 3

[Camrelizumab-induced intranasal reactive hemangiomas: a case series report].

2025 · H R Huang, L J Xu, et al. · PubMed · 1

Works count: 19

Citation count: 136

H-index: 5

I10-index: 4